ClinicalTrials.Veeva
Menu

Find clinical trials for Alzheimer's Disease in Aurora, CO

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Alzheimer Disease
Cognitive Dysfunction
Dementia
Mental Disorders
Brain Diseases
Nervous System Diseases
Neurodegenerative Diseases

Alzheimer's Disease trials near Aurora, CO, USA:

Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

This study is to test LHP588 in persons who have mild to moderate Alzheimer's disease (AD) who have shown progressive mental declin...

Enrolling
Alzheimer Disease
Alzheimer Disease Due to P. Gingivalis
Drug: Placebo Drug
Drug: LHP588

Phase 2

Lighthouse Pharmaceuticals, Inc.

Englewood, Colorado, United States and 38 other locations

Recently updated

Alzheimer's disease (AD) is a progressive, irreversible neurological disorder and is the most common cause of dementia in the elder...

Enrolling
Alzheimer's Disease
Drug: ABBV-1758
Drug: Placebo for ABBV-1758

Phase 1, Phase 2

AbbVie
AbbVie

Boulder, Colorado, United States and 11 other locations

FDA-approved for bone marrow stimulation (called sargramostim) will be tested for its safety and efficacy in individuals with mild-to-moderate Alzheimer's...

Enrolling
Alzheimer Disease
Drug: Saline - placebo comparator
Drug: Sargramostim

Phase 2

University of Colorado Denver (CU Denver)
University of Colorado Denver (CU Denver)

Aurora, Colorado, United States

and efficacy of ONO-2020 in participants with mild to moderate Alzheimer's disease (AD). This study aims to determine whether admin ...

Active, not recruiting
Alzheimer Disease
Drug: Placebo
Drug: ONO-2020

Phase 2

Ono Pharmaceutical Co., Ltd.

Englewood, Colorado, United States and 82 other locations

Xanamem® is being developed as a potential treatment for symptomatic, early stages of Alzheimer's Disease (AD) and Major Depressive...

Active, not recruiting
Alzheimer Disease
Dementia, Mild
Drug: Placebo
Drug: Xanamem

Phase 2, Phase 3

Actinogen Medical

Denver, Colorado, United States and 33 other locations

This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determin...

Active, not recruiting
Early Alzheimer's Disease
Drug: Lecanemab SC
Drug: Placebo

Phase 3

Eisai
Eisai

Denver, Colorado, United States of America and 247 other locations

55 to 90 years with hallucinations and delusions associated with Alzheimer's Disease Psychosis (ADP).The primary objective is to ev...

Enrolling
Psychosis Associated With Alzheimer's Disease
Drug: ML-007C-MA
Drug: Placebo

Phase 2

MapLight Therapeutics

Denver, Colorado, United States and 54 other locations

This is an open-label extension for a multicenter, randomized, double-blind, sham-controlled, adaptive design pivotal study.Participants who complete...

Invitation-only
Alzheimer Disease
Dementia of Alzheimer Type
Device: Sensory Stimulation System (GS120) - Active
Cognito Therapeutics
Cognito Therapeutics

Denver, Colorado, United States of America and 53 other locations

This AR1001-ADP3-US01 protocol is a double-blind, randomized, placebo-controlled, multi- center, parallel-group comparison pivotal Phase 3 study to e...

Active, not recruiting
Alzheimer Disease
Drug: Placebo
Drug: AR1001

Phase 3

AriBio

Denver, Colorado, United States of America and 199 other locations

The purpose of this study is to measure the difference in time to developing or worsening memory, thinking, or functional problems due to Alzheimer's...

Active, not recruiting
Alzheimer's Disease
Drug: Placebo
Drug: Remternetug

Phase 3

Lilly
Lilly

Aurora, Colorado, United States and 264 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems